Biological Therapy Analysis & Statistics, October 2014

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: stem cell, tissue engineering, cell therapy, more »

1-30 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Tissue Engineering and Regeneration: Technologies and Global Markets

Tissue Engineering and Regeneration: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report presents an in-depth analysis of the global tissue engineering and regeneration market by technologies, materials, applications segments and regional markets. It includes comprehensive ...

  • Industries : Biological Therapy
  • Countries : World
The Global Market for Stem Cells

The Global Market for Stem Cells

  • $ 6 650
  • Industry report
  • July 2014
  • by BCC Research

This BCC Research report provides detailed market, technology, and industry analyses to quantify and qualify the global market for prescription drug products. Important trends are identified and sales ...

  • Industries : Biological Therapy
  • Countries : World, United States, Europe, India, Canada, Germany, Japan, China, Brazil, Spain, Italy, France, Asia, Mexico, North America, United Kingdom
Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

The key to Transforming Future of Diagnostic and Therapeutic Medicine This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the ...

  • Industries : Biological Therapy
  • Countries : South Korea, World, Singapore, Australia, Malaysia, Thailand, Asia, Japan, India
Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) - Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

The global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on the ...

  • Industries : Biological Therapy
  • Countries : World, Europe, North America
Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

  • $ 4 650
  • Industry report
  • September 2014
  • by MarketsandMarkets

Over the years, the cell line development market has witnessed various technological advancements in order to cater to the growing demand for stable and high-yielding cell lines. These advancements have ...

  • Industries : Biological Therapy
  • Countries : World
Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...

  • Industries : Biological Therapy
  • Countries : United States
Global and China Stem Cell Industry Report, 2014-2017

Global and China Stem Cell Industry Report, 2014-2017

  • $ 2 250
  • Industry report
  • September 2014
  • by Research In China

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Stem cell therapy can be applied to treatment ...

  • Industries : Biological Therapy
  • Countries : China, World
Bone Regeneration - Pipeline Review, H2 2014

Bone Regeneration - Pipeline Review, H2 2014

  • $ 2 000
  • Company report
  • September 2014
  • by Global Markets Direct

Bone Regeneration - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Ophthalmics Partnering Terms & Agreements

Ophthalmics Partnering Terms & Agreements

  • $ 1 995
  • Industry report
  • August 2014
  • by Currentpartnering

The Opthalmics Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter opthalmics partnering deals. The majority of deals are discovery, preclinical ...

  • Industries : Biological Therapy
Global Gene Therapy Market Outlook 2018

Global Gene Therapy Market Outlook 2018

  • $ 1 500
  • Industry report
  • September 2014
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy Deals and Alliances of 2013

Cell Therapy Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • August 2014
  • by Currentpartnering

The Cell Therapy Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies ...

  • Industries : Biological Therapy
 B-Cell Leukemia-Pipeline Insights, 2014

B-Cell Leukemia-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ B-Cell Leukemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Biological Therapy
 Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Hematopoietic Stem Cell Transplantation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the ...

  • Industries : Biological Therapy
BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

BioHeart, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • September 2014
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

Cellectis S.A. (Symbol:ALCLS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Oxford Immunotec Limited SWOT Analysis, Strategy, Revenues and Profits

Oxford Immunotec Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States, Japan
ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

ReGenX Biosciences, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. ...

  • Industries : Biological Therapy
  • Countries : Australia, Singapore, United States
Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

Takara Bio Inc. (Symbol:4974) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

TiGenix NV (Symbol:TIG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Belgium, Spain
Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

Tissue Therapies Limited (Symbol:TIS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : Australia
Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

Pathfinder Cell Therapy, Inc. (PFND) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company's services include cell therapy. Its cell therapy is developing a novel cell-based therapy ...

  • Industries : Biological Therapy
  • Countries : United States
Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

Forticell Bioscience, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • October 2014
  • by Global Data

Summary Forticell Bioscience, Inc. (Forticell) is a biotechnology company. The company develops natural biomaterials and tissue engineered cellular therapies. Its product OrCel is used to stimulate the ...

  • Industries : Biological Therapy
  • Countries : United States
About 700 reports

Download Unlimited Documents from Trusted Public Sources

Opexa - Investor Report, October 2014

  • Opexa Therapeutics, Inc.
  • October 2014
    37 pages
  • Biological Ther...  

    Drug Discovery ...  

  • World  

View report >

Ethanol Supply In The Us

September 2014

32 Companies

Read our Company Profiles

StemCells Inc.

United States

Bioheart Inc.

United States

Aastrom Biosciences Inc.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.